Logo

NEPHROCARE HEALTH SERV L Share Price

NSE: NEPHROPLUS
|
Healthcare
₹ 671.95
-₹3.00 (-0.44%)
1D
Last updated 03 Jul, 2026, 15:57 IST

NEPHROCARE HEALTH SERV L Share Price Today

As of 5 Jul 2026, NEPHROCARE HEALTH SERV L share price is ₹671.95. The stock opened at ₹670.00, compared to its previous close of ₹674.95. During today's trading session, NEPHROCARE HEALTH SERV L share price moved in the range of ₹662.30 to ₹677.05, with an average price of ₹669.67 for the day. Looking at its last 52-week, the stock has touched a low of ₹446.00 and a high of ₹769.75. On the performance front, NEPHROCARE HEALTH SERV L share price has increased by 41.64% over the last six months and is up 42.59% on a year-on-year basis.


₹662.30
0.44% down today
₹677.05
1D LOW
1D HIGH

NEPHROCARE HEALTH SERV L Returns Calculator

Open
₹670.00
High
₹677.05
Low
₹662.30
Prev. close
₹674.95

Circuit
L
H
₹537.60
₹806.30
52-week
L
H
₹446.00
₹769.75

NEPHROCARE HEALTH SERV L Shareholder Returns

NEPHROCARE HEALTH SERV L Share Price History

Mkt Cap Cr
6,764.47

P/E
88.01

P/B
6.06

ROE
6.88%

D/E
0.01

ROCE
13.18%

Div. Yield
0.00%

EPS(TTM)
-0.89
Turnover
0.64

EV/EBITDA
26.70

Net Margin
0.00%

Op. Margin
0.00%

ROA
5.22%

Quick Ratio
0.00

Curr. Ratio
4.40
Based on fundamentals, this stock's
Step 3 of 5
Performance
Neutral
Nephrocare Health Services performance is moderate compared to markets
Step 1 of 5
Valuation
Overvalued
Nephrocare Health Services appears overvalued compared to its peers
Step 4 of 5
Earnings
Good
Nephrocare Health Services revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Apollo Hospitals1,25,057.0062.4513.2020.48%0.3217.27%692.920.23%0.70103.81
Max Healthcare1,09,728.0076.0810.2113.42%0.0912.97%91.860.18%0.287.37
Fortis Healthcare73,604.6069.157.4410.53%0.2312.56%122.240.10%0.163.05
Aster DM Healthcare40,962.6095.959.698.48%0.3110.10%83.230.38%0.465.20
Narayana Hrudayalaya40,570.7050.348.9417.76%0.7611.42%127.100.23%0.8524.77
Global Health36,176.7065.289.1314.05%0.0615.26%149.240.04%0.7718.46
KRISHNA INST OF MED SCI L35,097.80145.089.3710.74%0.637.99%93.540.00%0.466.52
Dr. Lal Path Labs27,697.1054.3311.0420.13%0.0725.56%8.901.56%1.0130.45
Syngene International17,755.4056.033.677.76%0.049.67%116.550.28%0.677.58
Poly Medicure17,614.2054.925.6710.37%0.0812.71%301.180.20%0.5333.15

NEPHROCARE HEALTH SERV L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹755.81₹566.16₹437.29₹317.67
Other Income₹14.10₹8.57₹5.96₹9.53
Total Revenue₹769.92₹574.72₹443.26₹327.20
Total Expenses₹682.48₹541.56₹451.85₹354.34
Profit Before Tax₹87.44₹33.16-₹8.59-₹27.14
Tax₹20.34-₹1.97₹3.20-₹5.81
Profit After Tax₹67.10₹35.13-₹11.79-₹21.33
EPS - Basic₹8.28₹4.55-₹67.95-₹130.96
EPS - Diluted₹8.01₹4.40-₹67.95-₹130.96

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹87.44₹33.16-₹8.59-₹27.14
Income before WC changes₹180.48₹113.35₹59.97₹37.41
Change in Assets-₹69.45-₹59.42-₹66.55-₹31.17
Change in Liabilities₹25.28₹26.42₹13.23₹12.89
Change in WC-₹44.17-₹33.00-₹53.32-₹18.28
Cash flow from Operations₹135.35₹72.28₹11.27₹14.35
Cash flow from Investing-₹125.07-₹50.66-₹78.21-₹129.30
Cash flow from Financing₹54.37₹26.74₹59.97₹121.29
Total Cash Flow₹64.65₹48.36-₹4.49₹6.04
Cash (Start of the year)₹61.15₹14.06₹18.55₹12.52
Cash (End of the year)₹125.82₹61.15₹14.06₹18.55

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹451.10₹415.98₹341.98₹286.07
Current Assets₹545.36₹390.03₹324.25₹284.57
Total Assets₹996.46₹806.02₹666.23₹570.64
Current Liabilities₹283.90₹242.59₹174.61₹93.77
Net Current Asset₹261.46₹147.45₹149.64₹190.81
Non-Current Liabilities₹128.45₹149.72₹102.99₹80.88
Equity Capital₹584.11₹413.71₹388.63₹396.00
Total Equity & Liabilities₹996.46₹806.02₹666.23₹570.64

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹543.60₹436.23₹386.11₹316.90
Other Income₹15.63₹7.80₹5.09₹3.56
Total Revenue₹559.23₹444.03₹391.20₹320.46
Total Expenses₹513.87₹443.82₹404.08₹348.53
Profit Before Tax₹45.36₹0.22-₹12.88-₹28.07
Tax₹11.12-₹3.67₹2.59-₹6.10
Profit After Tax₹34.24₹3.88-₹15.47-₹21.98
EPS - Basic₹4.23₹0.50-₹29.86-₹132.53
EPS - Diluted₹4.23₹0.50-₹29.86-₹132.53

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹45.36₹0.22-₹12.88-₹28.07
Income before WC changes₹104.27₹60.81₹44.57₹33.18
Change in Assets-₹52.40-₹21.96-₹45.57-₹26.62
Change in Liabilities₹22.47₹20.30₹8.19₹10.15
Change in WC-₹29.92-₹1.66-₹37.38-₹16.47
Cash flow from Operations₹79.73₹53.34₹11.14₹11.92
Cash flow from Investing-₹103.52-₹19.26-₹74.71-₹167.49
Cash flow from Financing₹26.02-₹35.54₹63.39₹147.37
Total Cash Flow₹2.23-₹1.46-₹0.18-₹8.20
Cash (Start of the year)₹1.62₹3.08₹3.26₹11.45
Cash (End of the year)₹3.85₹1.62₹3.08₹3.26

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹425.36₹408.02₹364.30₹316.95
Current Assets₹331.25₹256.55₹282.59₹254.96
Total Assets₹756.61₹664.57₹646.89₹571.91
Current Liabilities₹154.90₹185.03₹156.85₹84.78
Net Current Asset₹176.36₹71.53₹125.73₹170.17
Non-Current Liabilities₹59.71₹75.33₹93.39₹75.13
Equity Capital₹542.01₹404.22₹396.65₹411.99
Total Equity & Liabilities₹756.61₹664.57₹646.89₹571.91
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
671.95
132
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 132
Buy orders: 0%
Sell orders: 100%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict

RSI (14)
49.45
Neutral

ATR (14)
31.08
Neutral

STOCH(9,6)
22.64
Neutral

STOCH RSI (14)
14.02
Bullish

ADX(9)
24.92
Bearish

UO(9)
43.36
Neutral

ROC(12)
-9.57
Bearish

WillR(14)
-79.94
Neutral
Period
Simple value
Exponential vaue

5D
672.19
675.38

10D
684.7
682.37

20D
701.83
681.37

50D
632.21
648.56

100D
592.75
659.85

About NEPHROCARE HEALTH SERV L

NEPHROCARE HEALTH SERV L logo
ISIN
INE428V01029
Sector Market Cap
₹ 6,764.47 Cr

Nephrocare Health Services Limited, formerly Nephrocare Health Services Pvt Ltd, is an India-based company. The Company is primarily engaged in the business of providing dialysis and sale of related healthcare services and products. The Company offers comprehensive dialysis care through the network of clinics from diagnosis to treatment and wellness programs including hemodialysis, home and mobile dialysis, supported by a pharmacy. It has a network of approximately 490 clinics, with 43 clinics internationally across the Philippines, Uzbekistan and Nepal. Its subsidiaries include Nephrocare Health Services Central Asia FE LLC, Nephrocare Health Services International Pte. Ltd, Nephrocare Health Services Nepal Private Limited, and others.

NEPHROCARE HEALTH SERV L Financial Highlights

  • Revenue: NEPHROCARE HEALTH SERV L reported revenue of ₹1,023.36 crore in FY26 vs ₹769.91 crore in FY25. It showed an increase of 32.92% on a yearly basis.
  • Operating Profit: NEPHROCARE HEALTH SERV L reported an operating profit of ₹97.47 crore in FY26 vs ₹87.44 crore in FY25. It showed an increase of 11.47% on a year-on-year basis.
  • Net Profit: NEPHROCARE HEALTH SERV L reported a net profit of ₹76.84 crore in FY26 vs ₹67.10 crore in FY25. It showed an increase of 14.52% on a yearly basis.

NEPHROCARE HEALTH SERV L Quarterly Result Highlights

  • NEPHROCARE HEALTH SERV L reported revenue of ₹277.19 crore in Mar 2026, compared with ₹263.05 crore in Dec 2025, representing an increase of 5.38% on a quarter-on-quarter (QoQ) basis.
  • NEPHROCARE HEALTH SERV L reported an operating profit of ₹33.22 crore in Mar 2026, compared with ₹36.36 crore in Dec 2025, representing a decrease of 8.64% on a quarter-on-quarter (QoQ) basis.
  • NEPHROCARE HEALTH SERV L reported a profit of ₹30.37 crore in Mar 2026, compared with ₹32.24 crore in Dec 2025, reflecting a decrease of 5.80% on a QoQ basis.
  • The earnings per share (EPS) of NEPHROCARE HEALTH SERV L stood at ₹8.28 during Mar 2026.
Know more
Promoters
63.85%
FII
9.94%
Other DII
5.47%
Retail and other
17.56%
Mutual funds
3.17%
Foreign institutions - FII
Compare against other stocks
NEPHROCARE HEALTH SERV L logo
NEPHROCARE HEALTH SERV L
Healthcare
Add Stock
Add Another

FAQs on NEPHROCARE HEALTH SERV L Share Price